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Summary 
BACKGROUND: The introduction of newborn hearing screening has 
led to earlier identification of children with congenital sensorineural 
hearing loss (SNHL). Aetiological clarification offers several benefits. 
There is currently a lack of agreement on which examinations 
should be recommended. 
OBJECTIVE: Descriptive review of the literature reporting investiga-
tions performed to establish the aetiology of congenital SNHL and 
comparison of the management policy in Swiss referral centres. 
METHODS: PubMed Search from 1985 to March 2016 with specific 
search terms; study selection according to inclusion/exclusion 
criteria; narrative analysis by use of defined criteria and question-
naire. 
RESULTS: Ninety-two studies were finally included in this review. 
Forty studies investigated more than a single aetiology. Overall 
frequencies of aetiological parameters investigated were: genetic 
(47 studies), radiological (35), ophthalmic (35), serological (32), 
cardiac (25), renal (14), endocrine (12), neurological (8). Most of the 
studies were retrospective and various limitations such as poor 
population description, incomplete data or deficiencies in meth-
odological quality were frequently detected. The variability detect-
ed in the investigative approach chosen by Swiss referral centres 
reflects the heterogeneous data seen in the literature. 
CONCLUSIONS: The evidence in the literature regarding an appro-
priate evaluation is mostly of low quality and difficult to assess 
owing to high heterogeneity. Nevertheless, imaging, genetic test-
ing, neuropaediatric and ophthalmological evaluations, electrocar-
diograms and cytomegalovirus analysis have been identified as 
examinations to be included in the assessment of children with 
congenital SNHL. There is a need for international consensus on the 
various issues of such an evaluation, such as choice of investiga-
tions and diagnostic criteria. 
Key words: sensorineural hearing loss; congenital; evaluation; 
aetiology; management 
Introduction 
The prevalence of bilateral congenital sensorineural hearing loss (SNHL) 
ranges between 1 and 3% in industrialised countries. According to 
epidemiological data, the origin of congenital SNHL can be traced to a 
genetic cause in more than 50% of cases, and the remainder are consid-
ered as acquired [1]. Genetic SNHL is further subdivided into syndromic 
(30%) and nonsyndromic (70%) forms. 
The timely detection of congenital SNHL is of utmost importance as 
hearing therapy initiated before the age of 2 years (prior to the critical 
period for auditory development and speech acquisition) shows better 
results than therapy begun at a later age [2]. For this reason, universal 
newborn hearing screening was successfully introduced in many coun-
tries, including Switzerland since 1999, with the aim of detecting SNHL 
in the first few months of life [3, 4]. Early intervention once SNHL is 
confirmed is well established, whereas clarifying the aetiology is much 
less practised, although many benefits would ensue. These include 
prognostic counselling, avoidance of unnecessary screening investiga-
tions and, probably, a reduction in healthcare costs associated with over-
investigation. On the parental side, feelings of culpability and partner-
ship difficulties can be alleviated, and answers as to why their children 
have SNHL can be provided. Also, questions such as prediction of 
hearing outcome can be answered more precisely, as was shown for 
children with mutations in GJB2 who had a homogenously excellent 
outcome after cochlear implantation [5]. Although guidelines have been 
established, the proposed diagnostic approach for children with congeni-
tal SNHL varies [6, 7]. Therefore, recommendations for appropriate and 
cost-effective investigations in order to establish an aetiological diagno-
sis still remain unclear. New technology and heterogeneous practices 
further complicate the proper appraisal of investigative methods [8]. 
This study aimed to review the literature on assessing the aetiology of 
congenital bilateral SNH and to analyse the various investigations. In 
order to be able to focus on one group of children with hearing impair-
ment, unilateral and late-onset hearing loss were excluded. Secondly, 
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findings were compared with the management policy in Swiss referral 
centres, in order to define areas of improvement. 
Methods 
The Working Group “Paediatric Otorhinolaryngology” of the Swiss 
Society of Otolaryngology conducted a literature search in Medline 
(www.pubmed.gov) for the period from 1986 to March 2016. Earlier 
years were not included because a major shift in the frequency of the 
various aetiologies of congenital SNHL occurred, mainly as a result of 
two factors: the implementation of vaccination programmes for rubella 
and Haemophilus influenza, and the increasingly widespread use of 
computed tomography (CT) scans, which allowed the detection of new 
aetiological entities. The following keywords were used to extract the 
relevant articles in PubMed: “bilateral” AND “congenital” AND “senso-
rineural hearing loss” AND (each word separately) “neurology, heart, 
nephrology/kidney, radiology, infection, ophthalmology, genetics, 
endocrinology, serology”. Additional articles were identified from 
review of the reference lists. The inclusion criteria for the study selection 
were: patient age up to 18 years, any language, bilateral hearing loss, 
severity of hearing loss at least mild, at least one investigation defined, 
congenital hearing loss. Exclusion criteria were: progressive and/or 
unilateral hearing loss, age above 18 years. 
The validity of studies regarding “aetiology” is difficult to assess, as they 
are always limited by their retrospective nature; hence, criteria such as 
those established by the Centre for Evidence Based Medicine cannot be 
applied. Instead, internal validity was assessed by analysis of the com-
prehensiveness of documentation (precise methodology, well-described 
population, type and frequency of investigations, positivity criteria 
listed). The dataset was reviewed by at least two of the authors. Disa-
greements were reconciled through group discussions. 
Additionally, the result of the literature analysis was compared to the 
procedures employed in all otolaryngological tertiary referral centres in 
Switzerland, which cover >95% of paediatric cases with bilateral con-
genital SNHL. A questionnaire asking for the following information was 
sent to each institution: patient history, and results of neurological and 
ophthalmological examinations, electrocardiogram (ECG), serological 
and genetic analysis, endocrinology, urinalysis and radiology. Switzer-
land is a small country with defined tertiary referral centres for otolaryn-
gology. The questionnaire was developed by the group. The response 
rate was 100%. Finally, the costs of each examination were evaluated. 
Results 
Literature analysis: general 
After the initial literature search, the abstracts of >1600 published arti-
cles were searched for the predefined inclusion and exclusion criteria for 
the study selection. Twelve studies were excluded because of unspecified 
investigations and/or lack of precise population description [9–20]. 
Ninety-two were finally included in this study. For three of these only 
abstracts were available [21–23] (see appendix 1). Forty studies investi-
gated more than a single aetiology [8, 24–62]. The studies were charac-
terised by high heterogeneity of various factors: study population, patient 
age, type of examination, completeness of data, reporting of results 
(tables 1 and 2). For instance, although all studies included patients with 
congenital onset of hearing loss, the exact characterisation was not 
available in 46 (50.5%) [8, 21, 25, 27–30, 34, 35, 39–42, 44, 48–50, 53, 
55–57, 59–61, 63–84]. Another complicating factor for analysis was the 
fact that the frequency of the various investigations was highly variable 
within each study population. 
The following type of studies were identified in this review: retrospec-
tive case studies (47 studies), cross-sectional (13), cohort studies (11), 
case-control studies (11), prospective case studies (9) (see also tables 1 
and 2). The following types of aetiological parameters were investigated, 
in order of the number of studies for which they were reported (table 3): 
genetic (47 studies), radiological (35), ophthalmological (35), serological 
(32), cardiac (25), renal (14), endocrine (12) and neurological (8). 
Literature analysis: investigations 
The range of the results obtained from the various investigations was 
very wide (tables 1 and 2). Equally, the type and number of investiga-
tions showed great variety and range of frequency across the selected 
studies (table 3). 
History was typically investigated. In the majority of studies there was 
no clear indication of precisely how history was taken. Thirty percent of 
the studies gave a detailed description; risk factors, such as established 
by the Joint Committee on Infant Hearing, were referred to in the minori-
ty (tables 1 and 3) [85]. 
Chemistry and urinalysis were commonly ordered to detect renal in-
volvement (tables 1 and 3) [26, 29, 31, 35–37, 39, 49, 50, 52, 53, 55–57]. 
Four studies additionally employed renal ultrasound [26, 29, 37, 57]. 
Cardiac evaluation (ECG) was performed in 25 studies, in 8 as a single 
examination (tables 1, 2 and 3) [9, 22, 24, 26, 29, 31, 32, 35–38, 49, 50, 
52, 53, 55, 57, 58, 60, 86–92]. Echocardiography constituted an addi-
tional investigation in three studies [26, 87, 90]. 
Serological test results for toxoplasmosis, rubella, cytomegalovirus, 
herpes (commonly known as TORCH infections) and syphilis were 
found in 32 studies (tables 1, 2 and 3) [24, 25, 29, 31, 32, 34–37, 42–44, 
46–48, 50, 51, 53–55, 57, 60–62, 64, 66, 75, 78, 80, 93–95]. Eight of 
these analysed infectious agents as single aetiological factors (table 2) 
[64, 66, 75, 78, 80, 93–95]. 
The benefit of and procedures used for a neurological examination were 
only rarely evaluated (tables 1, 2 and 3). Eight studies included devel-
opmental assessment and/or an electroencephalogram in their protocol 
[12, 26, 35–37, 55, 59, 61, 96]. 
Twenty-five studies included radiology as part of a comprehensive work-
up (table 1) [8, 24–26, 29–33, 35–37, 43, 45, 47, 49, 50, 52–54, 57–61]. 
In an additional 10 studies radiology constituted the single investigative 
modality (table 2) [71, 76, 79, 97–103]. 
The majority of the studies (31) employed computed tomography (CT) 
with, where indicated, 1 to 2 mm slice thickness. Magnetic resonance 
imaging (MRI) was additionally performed in 16 studies [24, 26, 32, 33, 
37, 45, 50, 53, 54, 58–60, 101–103] (table 3). Kimani et al. reported MRI 
results only [47]. 
Thirty-five studies reported the results of ophthalmic evaluation, 14 as a 
single analysis (tables 1 and 2) [12, 31, 32, 35–39, 41, 45, 49, 52, 53, 55–
63, 65, 67, 69, 70, 74, 77, 82, 83, 104–108]. Six tests were performed at 
variable frequencies: visual acuity, refraction error measurement, fun-
doscopy, retinoscopy, electroretinography and electro-oculography (table 
3). However, the last two of these tests were listed in only six and two 
studies, respectively [57, 61, 62, 65, 77, 83, 105, 106]). 
Twelve studies included thyroid function tests; the perchlorate test was 
reported only once (tables 1 and 2) [29, 31, 32, 35–37, 39, 49, 50, 53, 55, 
57]. 
A genetic investigation was reported in 47 studies, in the majority as part 
of a comprehensive work-up, and as a single aetiological test in 11 
(tables 1 and 2) [9, 21, 23, 29, 31–38, 40–42, 44–49, 51–62, 68, 72, 73, 
109–112] [8, 24, 26–28, 113, 114]. A wide range of tests performed 
reflected technological development and local availability: chromosome 
analysis, clinical genetic examination, mutation analysis (table 3). Mo-
lecular analysis has become increasingly widespread and applied. 
Thirty studies included molecular screening of gap-junction protein β2 
(GJB2) and reported a positive finding in 1 to 59% (tables 1 and 2) [21, 
23, 24, 29, 32–34, 37, 38, 40, 45–48, 51, 53–55, 59, 60, 68, 72, 73, 109–
114]. Additional genes were analysed less frequently: GJB6 (7 studies), 
SLC26A4 (6), mitochondrial genes (4) and GJB3 (1). 
Literature analysis: aetiologies 
Taking a thorough history yielded a positive result in 10 to 50% of cases 
(table 1) [14, 29, 31, 35, 36, 39, 49, 50, 52, 53, 55–57] 
Abnormal results of renal investigations were found in up to 10% of 
patients tested (table 1). However, Alport’s syndrome or branchio-oto-
renal syndrome were identified in two studies only, with an incidence of 
2.5% at most [36, 49, 50]. 
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Similarly, a high rate of abnormal results (prolonged QT interval) was 
reported in up to 16% of cardiac examinations, but the true incidence of 
the long QT syndrome was much lower at 0 to 4% (tables 1 and 2). 
Serological testing constitutes an integral part of the work-up. Rubella 
shows a substantial decline as a prominent aetiological factor in coun-
tries with high immunisation rates (table 1). The virus remains in coun-
tries with poorly designed immunisation programmes or immigrants 
originating from these areas [8, 27, 28, 43]. In contrast, cytomegalovirus 
(CMV) has become more prevalent, with more recent studies consistent-
ly reporting rates of between 5 and 20% (tables 1 and 2) [32, 37, 44, 46, 
47, 64, 66, 80, 94, 95]. In all these studies, analysis was performed on 
either dried-blood spots or umbilical cord, both of which are valid meth-
ods for detecting congenital infection. Two studies with much higher 
percentages stand out. One study from Iran found a 35% rate of acute 
immunity by determining IgM levels in blood samples [78]. The test 
method was not clearly identifiable in another study, from Poland, with a 
reported rate of 55% [51]. 
Exact figures for neurological findings, such as developmental delay and 
intellectual deficit or encephalographic abnormalities, have been found 
in only four studies, with a wide range and usually not clarifying the 
aetiology (tables 1 and 2) [26, 35, 59, 96]. The clinical approach to 
detecting developmental delay and intellectual deficit led to higher 
frequencies (33 to 70%) than electroencephalography (between 13 and 
40%). 
Abnormalities of the inner ear and the vestibulocochlear nerve were 
described in 10 to 88%. Enlarged vestibular aqueduct constituted the 
most frequently detected malformation [30, 50, 53, 71, 97, 98]. The 
remaining studies reported malformations of the cochlea, semicircular 
canal or vestibule as the most frequent or did not list the frequency of 
malformations. Two studies listed additional intracerebral findings 
detected on MRI [50, 59]. 
Ocular abnormalities were detected in up to 60%. The studies specifical-
ly examining the eyes showed a higher mean of 40% (tables 1 and 2). 
Visual impairment and refractive errors were the most frequent findings, 
with an incidence of 23 to 50%. Guy et al. reported the highest rate of 
retinitis pigmentosa (5%) by recording the electroretinogram [105]. In 
contrast, a much lower rate (0 to 2%) was found in two other studies 
without electroretinogram recordings [74, 108]. 
Abnormal results of thyroid function tests were found in five reports, but 
only two of them confirmed cases of Pendred syndrome [35, 49]. 
A genetic cause was found in 1 to 70%. A syndromic form of congenital 
SNHL was detected with a mean of frequency of 12.5% (tables 1 and 2). 
Twenty-five studies included molecular screening of GJB2 and reported 
a positive finding in 1 to 59% of those tested (mean 15%; tables 1 and 2) 
[21, 23, 29, 32–34, 37, 38, 40, 44–48, 51, 53–55, 59, 60, 68, 72, 73, 109–
112, 115]. 
Additional tests (blood count, lipids, autoimmune antibodies) were used 
only sporadically and did not contribute to the aetiological clarification. 
In spite of thorough analysis the aetiology remained unknown in about 
30% of cases (table 1). 
Reported practice of Swiss otolaryngological tertiary referral 
centres 
There is high variation between the centres in the preferred examinations 
(table 4). Most are not performed on a routine basis. No centre under-
takes a complete search. Radiological examination and genetic analysis 
were the preferred investigations and were ordered for 60 and 50% of 
patients, respectively. The frequency of the examinations ordered and the 
results were not available. Typical reasons for an incomplete analysis 
were organisational difficulties and parental restraints. 
Cost analysis 
The costs of all examinations are listed in table 5. The total was 1720 
Swiss francs based on the Tarmed (current country-wide official tariff). 
The most expensive tests are genetics and radiology (analysis of GJB2 
and CT/MRI), which make up 60% of the total costs. 
 
Table 1: List of studies (in chronological order) with >1 aetiology investigated. 
First 
author 
(type of 
study†) 
Year Class of aetiological investigation (percentage with positive findings) Number of 
patients‡ 
(age§) Endo-
crine 
Genetic History Cardiac Renal Neuro-
logical 
Ophthal-
mic 
Radio-
logical 
Serological Other UK 
Das (1) 1988 1 27.5 syn-
dromic 3.7 
20.7 n.a. n.a. 33 n.a. n.a. 9.8 (CMV 5.5 rubella 4.3) 3 (metabolic 
disorder) 
35 164 (age: mean 
21.5 m) 
Lenzi (1) 1988 0.2 30 30 0.1 0.1 – n.a. n.a. 10 (rubella) 3 26.5 85 (age: n.a.) 
Derey-
maeker (2) 
1991 – 39 syndromic 
4 
46 – – – n.a. – 16 (CMV 1, rubella 15) – 15 155 (age: 83% 
<3 y) 
Elango (3) 1992 – 14 syndromic 
0.15 
51 – – – – – 6.5 (rubella 6.4 syphilis 0.1) – 28.5 155 (age: 1–12 
y) 
Elango (3) 1993 – 18 syndromic 
0.1 
26 – – – 35 – 36 (rubella) – 20 167 (age: 7–
15 y mean 
9.9 y) 
Vannia-
segaram (3) 
1993 n.a. 40 21 n.a. n.a. – – n.a. 8 (rubella 6, CMV 2) – 30 98 (age: 2 w–
12 y) 
Das (1) 1996 n.a. 39 syndromic 
5 
20 n.a. n.a. n.a. n.a. n.a. 8 (rubella 5, CMV 3) – 34 339 (age: mean 
2 m) 
Parving (1) 1997 – 48.5 syn-
dromic 19.5 
17 n.a. n.a. – n.a. n.a. 7.5 – 27 93 (age: n.a.)  
Vartiainen 
(3) 
1997 – 59.5 syn-
dromic 20 
20 n.a. – – n.a. n.a. – – 21.5 65 (age: mean 
4.5 y)  
Billings (3) 1999 – n.a. syndrom-
ic 12.5 
32 – – – – 8.5 – – 27 241 (age: n.a.)  
Dereköy (2) 2000 0 24 22 – 0 – n.a. – – 27 (febrile 
convulsions) 
26 130 (age: 5–
16 y) 
Zakzouk (3) 2001 – 47 syndromic 
2.3 
16 – – n.a. n.a. 16.6 6 (toxoplasmosis 1.5 rubella 
0.75, CMV 0.75 herpes 3) 
9 21 302 (age: 3 m–
12) 
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Table 1 (continued) 
Bojano (1) 2002 n.a. 62.5 syndromic 13 13.5 n.a. n.a. – n.a. n.a. n.s. 4 20 178 (age: n.a.) 
Mafong (3) 2002 0 n.a. n.a. 1 0 – – n.a. 0 (only syphilis) 0 n.a. 95 (age: n.a.) 
(unknown aetiology 
only) 
Fageeh (2)  2003 – 70 n.a. – – – – 5 8 (toxoplasmosis 3, 
rubella 5) 
– n.a. 100 (age: mean 2 y) 
Deben* (3) 2003 – 39 syndromic 4.5 8.5 0.1 0 13 13 15 9 (rubella 1.5, CMV 7) – 52 179 (age: 2–14 y, 
median 8.5 y) 
Al Khabori 
(3) 
2004 – n.a. 13 – – – – – 1.5 (rubella) – 53 1400 (age: n.a.) 
Preciado* (3) 2004 0 18 (GJB2/ SLC26A4) – 0.1 0 – 14 25 (CT n.a., 
MRI n.a.) 
0 0 n.a. 496 (age: n.a.) 
(unknown aetiology 
only) 
Dent (2) 2004 – 32 syndromic 16 (GJB2, 
A1555G, A7445G) 
n.a. 0 – – n.a. – – 4 64 24 (age: n.a.) 
Silan (2) 2004 – 63 syndromic 18 19 – n.a. – n.a. – – – 18 443 (age: 1 m–4 y, 
median 2.4 y) 
DeNo-brega 
(1) 
2005 – 17 25 – – – – – 18 (rubella) – 40 244 (0–2 y) 
Riga (3) 2005 n.a. 47 syndromic 11 
(GJB2(35delG only) 4.5) 
35.5 n.a. n.a. n.a. n.a. – 2.5 (CMV 2, rubella 
0.5) 
n.a. 15 153 (1 m–13 y, 
average 3 y) 
Yoong (3) 2005 – 70 (GJB2 0) 7 0 – – n.a. 0 n.a. – 23 42 (age: n.a.) 
Lasisi (3) 2006 – 54 42 – – – – n.a. 0 0 4 48 (mean 6 y) 
Declau* (4) 2008 0 60 syndromic 2 (GJB2, 
GJB6 9.5) 
21 0.9 0 NS 4.5 30 (CT 27, 
MRI 21) 
8 (CMV) – 45 68 (age: 1–3 m) 
Dietz (3) 2009 – 46 syndromic 11 (GJB2 14) 14 – – – – – – – 40 92 (age: median 5 y)  
Bajaj (2) 2009 n.a. 60 syndromic 15 (GJB2 17) 18 n.a. n.a. – – n.a. 0.8 (CMV) n.a. 22 134 (age: 9 m–18 y, 
average 11.6 y) 
Boude-Wyns 
(4) 
2009 n.a. 41.5 syndromic 5 (GJB2 5) 15 n.a. - – n.a. n.a. 7 (CMV) – 56 59 (age: n.a.) 
Korver (1) 2010 – 39 syndromic 16 
(GJB2/SLC26A4) 
35 – – – – – 10 (CMV9, rubella) – 26 171 (age: 3–5y)  
Kimani (3) 2010 – 10 (GJB2 9, A1555G 1) – – – – – 37 (MRI) 10 (CMV 9) –  95 (age: 1–5y) 
Johnston (3) 2010 – 42 syndromic 25 (GJB2 5) n.a. – – – 32 n.a. – – n.a. 77 (age: mean 7 y) 
Chan (3) 2010 – 20 (GJB2) – – – – – 14 (CT) – –  271 (age: mean 
5.8 y) 
Siem (3) 2010 – 42 syndromic 15 
(GJB2/GJB6 22, SLC26A4 4) 
22 2.5 – – – n.a. (CT/ 
MRI) 
2 (CMV 1.5, rubella 
0.5) 
– 29 197 (age: median 
6 y) 
Wiley* (3) 2011 – 30 syndromic 9 (GJB2 10) 21 – – 70 55 34 (CT 3/ 
MRI 32) 
– 19 (structural 
anomalies) 
32 90 (age: 1 m–17 y) 
Furutate (3) 2011 – 22 (GJB2 5, SLC26A4 7) – – – – – – 9 (CMV) –  46 (age: 11–39 m)  
Milewska (3) 2011 – 27 (GJB2) – – – – – – 55 (CMV) –  157 (age: n.a.) 
Karltorp (1) 2012 – 4 (GJB2) – – – – – – 17 (CMV) –  87 (age: n.a.) 
Elziere (3) 2012 – 45 40 – – – n.a. 30 (CT) 5 (rubella) – 15 20 (age: mean 7 y) 
Dahl (1) 2013 – 24 (GJB2 13, SLC26A4 2) 17 – – – – – 8 (CMV) – 64 364 (age: n.a.) 
Ramos (1) 2013 – 42 (GJB2/ GJB6, A1555G) 29 – – – – 10 n.a. – 26 38 (age: 5–21 m)  
Mean  0.2 37 25 0.3 0 39 29.8 20 6.8 Not calculated 31.4 Total number: 7362 
Range  0–1 4–70 8.5–
51 
0–
2.5 
0–
0.1 
13–
70 
13–
55 
5–37 0.75–17  4–64  
CMV = cytomegalovirus; CT = computed tomography; GJB2 = gap-junction protein β2 (connexin 26); GJB3 = gap-junction protein β3 (connexin 31); GJB6 = gap-junction protein β6 
(connexin 30); MRI = magnetic resonance imaging; n.a. = not available (cannot be indicated owing to lack of information, mixed population etc.); SLC26A4 = solute carrier family 26 
member 4 (Pendrin); 12S rRNA/tRNAser = mitochondrial genes; UK = unknown 
* More substantive studies with regard to established quality criteria  
† Type of study: (1) = cohort study, (2) = cross-sectional study, (3) = retrospective case study, (4) = prospective case study 
‡ Patients with bilateral hearing loss  
§ Age at time of diagnosis or examination 
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Table 2. List of studies (in chronological order) with a single aetiology investigated. 
Class of  
aetiological 
investigation 
First author  
(type of study*) 
Year Investigation Percentage  
of positive results 
Number of patients (age) 
Genetic  
11 studies 
Kenna (1) 2001 GJB2 18 n.a. (age: n.a.) 
Dahl (2) 2001 GJB2 21 243 (age: 1 m–16 y, median 4 y) 
Wang (3) 2002 GJB2 7 169 (age: 4–18 y) 
Lim (4) 2003 GJB2 17 160 (age: <19 y) 
Gurtler (3) 2003 GJB2 15 20 (age: < 2 y) 
Erbe (1) 2004 GJB2, GJB6 26 68 (age: 2 m–18 y) 
Evirgen (4) 2008 GJB2, GJB6 (only 35delG, 167delT, del(GJB6-D13S1830)) 8.5 47 (age: 8–18 y) 
Yuan (3) 2009 GJB2, GJB3, GJB6, SLC26A4, 12S rRNA, and tRNAser n.a. 94 (age: n.a.) 
Hayashi (3) 2011 GJB2 30 126 (age: 0–3 y) 
Lalaiants (1) 2011 GJB2 59 66 (age: several months) 
Javidnia (4) 2014 GJB2, GJB6 <1% 122 (<18 y) 
   Median (range): 20 (1–59)  
Cardiac  
8 studies 
Ocal (4) 1997 ECG (additionally in 2.5%: Holter-ECG, cchocardiography) 0.5 350 (age: 6–18 y) 
Rokicki 2002 ECG 1.2 162 (age: 3–15 y, mean10.5 y) 
El Habbal (3) 2002 ECG, echocardiography 0 52 (age: 0.2–17 y, median 8.4 y) 
Sopon-tammarak (5) 2003 ECG 0.7 276 (age: n.a.) 
Sathya-murthy (5) 2009 ECG 0 127 (age: 1.2–10 y) 
Chinagudi (5) 2010 ECG 4 50 (age: 6–18 y) 
Niaz (5) 2011 ECG 3 104 (age: n.a.) 
Kang (4) 2011 ECG 0.7 193 (age: n.a.) 
   Median (range): 0.6 (0–4)  
Ophthalmic  
14 studies 
Woodruff (4) 1986 Visual acuity, refraction error, fundoscopy, retinoscopy 55 460 (age: n.a.) 
Rogers (5) 1988 Visual acuity, refraction error, fundoscopy, retinoscopy, 
electroretinogram 
43 n.a. (age: n.a.) 
Leguire (5) 1992 Visual acuity, refraction error, electroretinogram, 
electro-oculogram, visual-evoked responses 
24 505 (age: 6–22 y, mean 12 y) 
Elango (5) 1994 Visual acuity, refraction error, fundoscopy, retinoscopy 58 165 (age: n.a.) 
Siatkowski (4) 1994 Visual acuity, refraction error, fundoscopy, retinoscopy 61 54 (age: 2–14 y, mean 6 y) 
Armitage (3) 1995 Visual acuity, refraction error, fundoscopy, retinoscopy 46 83 (age: 16 m–16 y, mean 9.5 y) 
Young (4) 1996 Visual acuity, refraction error, fundoscopy, retinoscopy, 
electroretinogram 
10 47 (age: 6 m–9 y, average 3 y) 
Brinks (1) 2001 Visual acuity, refraction error, fundoscopy, retinoscopy, 
electroretinogram 
48 4 (age: 10–21 y) 
Mafong (4) 2002 n.a. 31 95 (age: n.a.) 
Guy (4) 2003 Visual acuity, refraction error, fundoscopy, retinoscopy, 
electroretinogram 
44 110 (age: 8 m–16.9 y) 
Hanioglu (4) 2003 Visual acuity, refraction error, fundoscopy, retinoscopy 40 104 (age: 7–20 y) 
Bakhshaee (5) 2009 Visual acuity, refraction error, fundoscopy, retinoscopy 32 50 (age: 3–7 y, mean 4.3 y) 
Sharma (4) 2009 n.a. 22 174 (age: n.a.) 
Falzon (4) 2010 Visual acuity, fundoscopy, retinoscopy 42 141 (age: 16 m–9y, mean 28 m) 
   Median (range): 40 (10–61)  
Infection/ 
serological  
8 studies 
Samileh (3) 2008 CMV 35 75 (age: n.a.) 
Noor-bakhsh (3) 2008 Toxoplasmosis 12 75 (age: n.a.) 
Choi (3) 2009 CMV 3 n.a. (age: infant) 
Tagawa (4) 2009 CMV 12 36 (age: n.a.) 
Avettand (1) 2012 CMV 8 100 (age: 2–37 m, mean 15 m) 
DeVries (1) 2012 CMV 14 76 (age: <6 y) 
Toumpas (4) 2014 CMV 5 118 (age: <18 y) 
Courtmans (4) 2015 CMV 11 75 (age: 1 m–15 y) 
   Median (range): 12.5 (3–35)  
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Table 2 (continued) 
Radiological  
10 studies 
Shusterman (4) 1992 CT 13 32 (age: 1–21 y, average 6.7 y) 
Cross (4) 1999 CT 11 71 (age: 13–20 y) 
Antonelli (4) 1999 CT 31 n.a. (age: n.a.) 
Westerhof (4) 2001 CT, MRI 88 21 (age: 5 m–8 y, mean 3 y) 
Sennaroglu (4) 2002 CT, MRI 48 27 (age: 3–26 y, mean 11 y) 
McClay (4) 2002 CT 17 72 (age: n.a.) 
Purcell (4) 2003 CT n.a. 15 (age: 2–11 y, mean 8 y) 
Huo (4) 2012 CT 69 65 (age: 1–14 y, average 3.8 y) 
Nakano (4) 2013 CT 19 114 (age: 0–20y, median 6 y) 
Agarwal (1) 2014 CT, MRI 14 280 (age: 1–14 y) 
   Median (range): 34.5 (11–88)  
Neurological, 1 study El-Badry 2014 Electroencephalogram 42 90 (age:1–13 y, mean 3.8 y) 
CT = computed tomography; CMV = cytomegalovirus; ECG=electrocardiogram; GJB2 = gap-junction protein β2 (connexin 26); GJB3 = gap-junction protein β3 (connexin 31); GJB6: gap-
junction protein β6 (connexin 30); MRI = magnetic resonance imaging; n.a. = not available (cannot be indicated owing to lack of information); SLC26A4 = solute carrier family 26 
member 4 (Pendrin); 12S rRNA/tRNAser = mitochondrial genes. ‒ * Type of study: (1) = prospective case-study; (2) = cohort-study; (3) = retrospective case-study; (4) = case-control 
study; (5) cross-sectional study. ‒ Total number of patients = 5763 
Table 3: Number (percent) of studies including various aetiological investigations and 
type of examination. 
Endocrine Thyroid function test:12 (100) 
Perchlorate test:1 (8.5) 
12 
Genetic Clinical: 10 (21) 
GJB2: 30 (64) 
GJB6: 7 (15) 
SLC26A4: 6 (13) 
Mito. Genes: 4 (8.5) 
n.a.: 4 (8.5) 
47 
History Specified: 11 (30) 
n.a.: 26 (70) 
37 
Cardiac Electrocardiography: 24 (96) 
Echocardiography: 5 (20) 
n.a.: 1(4) 
25 
Renal Urin alysis: 13 (93) 
Creatinine: 3 (21) 
Ultrasound: 4 (28.5) 
n.a.: 1 (7) 
14 
Neurological Electroencephalography: 2 (25) 
n.a.: 6 (75) 
8 
Ophthalmic Fundoscopy: 17 (48.5) 
Retinoscopy: 16 (46) 
Visual acuity: 15 (43) 
Refraction error: 14 (40) 
ERG: 6 (17) 
EOG: 2 (6) 
n.a.: 15(43) 
35 
Radiological CT: 31 (88.5) 
MRI: 16 (46) 
X-ray: 2 (7) 
n.a.: 1 (3) 
35 
Serological CMV: 19 (59)  
TORCH: 8 (25) 
Syphilis: 7 (22) 
Rubella: 1 (3) 
n.a.: 3 (9) 
32 
Other Complete blood count: 5 (71) 
Electrolytes: 2 (28) 
ESR: 3 (43) 
Lipids: 2 (28) 
Glucose: 3 (43) 
Antinuclear antibody: 1 (14) 
Rheumatoid factor: 1 (14) 
7 
CMV = cytomegalovirus; CT = computed tomography; EOG = electro-oculography; ERG= 
electroretinogram; ESR = erythrocyte sedimentation rate GJB2 = gap-junction protein 
β2 (connexin 26); GJB6 = gap-junction protein β6 (connexin 30); MR I= magnetic 
resonance imaging; n.a. = not available; TORCH = toxoplasmosis, rubella, cytomegalovi-
rus, herpesvirus; SLC26A4: solute carrier family 26 member 4 (Pendrin) 
Table 4: Number (%) of major Swiss tertiary referral centres ordering various investiga-
tions. 
Type of investigation Yes No Not routinely 
History 8 (100%) 0 0 
Radiological (CT/MRI) 5 (62.5%) 2 (25%) 1 (12.5%) 
Urinalysis 2 (25%) 0 6 (75%) 
ECG 1 (12.5%) 0 7 (87.5%) 
Neurological 1 (12.5%) 0 7 (87.5%) 
Serological 1 (12.5%) 0 7 (87.5%) 
Ophthalmological 1 (12.5%) 0 5 (62.5%) 
Genetic 4 (50%) 3 (37.5%) 1 (12.5%) 
Endocrine 0 3 (37.5%) 5 (62.5%) 
CT = computed tomography; ECG = electrocardiogram; MRI = magnetic resonance 
imaging 
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Table 5: Costs of investigations. 
Price 
 
Type of investigation 
CT/ 
MRI 
ECG Urinalysis Serological Neurological GJB2 (connexin 
26) 
Endocrine Ophthalmic Total 
CHF 
(EUR, US$) 
650 
(585, 
650) 
30 
(27, 30) 
15 
(13.5, 15.) 
150 
(135, 150) 
240 
(216, 240) 
500 
(450, 500) 
25 
(22.5, 25) 
110 
(100, 110) 
1720 
(1549, 
1720) 
CT = computed tomography; ECG = electrocardiogram; MRI = magnetic resonance imaging 
All prices are for 2016 and in Swiss francs according to the official Swiss medical tariff (www. fmh.ch/TARMED Version 1.08.00) 
Exchange rates: 1.1 EUR/CHR; 1 US$/ 
 
 
Discussion 
With the successful launch of the newborn hearing screening in most of 
the so-called industrialised countries, children with congenital hearing 
loss are identified early and auditory rehabilitation including cochlea 
implants is well established. However, aetiological focus is often lacking 
[3]. There is no consensus on an evidence-based approach to an effective 
aetiological work-up. There is a lack of agreement not only on what to 
screen, but also on how to screen. This qualitative review aimed to 
clarify the current status of aetiologies and investigations for children 
with bilateral congenital SNHL in order to support evidence-based 
management and identify areas for future action. 
General descriptive analysis 
Various factors leading to very high heterogeneity in the published 
studies prompted the authors to follow a narrative approach in the dis-
cussion section. Deficiencies in methodological quality are a commonly 
observed fact. For instance, a standardised questionnaire for history 
taking was only used in 10 out of 18 studies (55%). Populations with 
different types of hearing loss were often mixed and were not analysed 
separately, leading to confounding percentages [31, 57, 61]. Incomplete 
testing of the populations contributing to variable percentages represent-
ed another frequent problem. 
Descriptive analysis of investigations/aetiologies 
The proper identification of the aetiology remains a challenge, as the 
exact contribution of a positive finding might be difficult to evaluate. 
Roizen et al. had already pointed out uncertainties in diagnosis in 2003 
after analysing nongenetic factors [116]. Hyperbilirubinaemia and thera-
py with aminoglycosides represent such examples. For both factors, 
neither the level nor duration of exposure causing hearing impairment 
has been defined. Therefore, even if the history is positive and is based 
on available recommendations such as those provided by the Joint 
Committee on Infant Hearing, additional aetiological factors have to be 
considered [85]. In this context, the question of positivity criteria should 
be further discussed, although a thorough discussion is beyond the scope 
of this review. Ten case-control studies identified in this review [63, 75, 
76, 78, 87, 93, 96, 111, 112, 114], mostly concerning genetics and infec-
tions, reported a higher prevalence of an aetiological factor in the hear-
ing-impaired population compared with the controls. Additionally, 
possible “dual” aetiologies, especially for GJB2 mutations and CMV, 
have been reported [46, 93]. Unless clear diagnostic criteria are estab-
lished, uncertainties remain regarding interpretation of results and will 
lead to a diagnostic challenge. 
Various investigations were ordered with the aim of detecting syndromic 
hearing loss, which was reported in the studies with a range of 0.1 to 
25%. Exact identification is important, as it may allow associated com-
plications to be anticipated and appropriately managed. Only 15% of the 
studies (2 out of 13, table 1) reported positive findings for urinalysis [36, 
49]. In both cases either additional features or follow-up led to the final 
diagnosis of Alport syndrome or branchio-oto-renal-syndrome. The same 
is valid for thyroid function tests, with an extremely low yield approach-
ing 0% (Table 1). A third investigation, imaging, was regularly ordered 
for the same purpose. In fact, enlarged vestibular aqueduct was the most 
frequent finding and may direct subsequent genetic analysis to confirm 
Pendred or enlarged vestibular aqueduct (EVA) syndromes. Imaging has 
additional advantages. Counselling can be improved, as malformations 
such as enlarged vestibular aqueducts are known to predispose individu-
als to sudden hearing loss after head trauma and are associated with a 
higher risk of meningitis [117]. A third benefit can be derived. Audio-
rehabilitation, such as cochlear implantation, is better managed if inner 
ear anomalies such as absence or presence of the cochleovestibular nerve 
or cochlear malformations are known. The choice of CT or MRI current-
ly depends mainly on the surgeon’s or institution’s practice. In a com-
parative study, both modalities showed the same detection rate of 
anomalies of the inner ear, and MRI was superior in evaluating the 
vestibulocochlear nerve [102]. Additional factors influencing the deci-
sion process were radiation exposure in the case of CT and the need for 
anaesthesia in the case of MRI. However, current protocols and technol-
ogy allow the radiation dose of a temporal bone CT to be reduced to less 
than 1 mSv and acquisition time for an MRI has become shorter, eventu-
ally eliminating the need for sedation. 
Another two types of investigation, ophthalmological and neurological, 
had a dual role in the evaluation process. The high prevalence of accom-
panying ophthalmic and neurological disorders stands in contrast to their 
power for identification of syndromes. The application of electrography 
clearly raises sensitivity and specificity to detect retinitis pigmentosa 
and, as a result, Usher syndrome (the most frequent oculoauditory syn-
drome) [105]. However, because the onset of retinitis pigmentosa is 
mostly during the first decade of life or even later (depending on the 
subtype), early investigation will underestimate the true incidence of 
Usher syndrome in children with congenital SNHL [118]. On the other 
hand, knowledge of the ocular status is important, as visual impairment 
can hinder sign language and pose a severe handicap to developing 
communication skills. The same is true for neurological deficits such as 
developmental delay, which might require additional educational care. 
The prevalence seems to be high, although exact percentages were 
reported in only four studies [12, 35, 36, 59]. 
A routine complete serological analysis can be regarded as not indicated, 
with the exception of CMV serology. In studies and reviews, such as 
those by Avettand et al. and Morton et al., CMV has been confirmed as 
the most prevalent environmental cause for congenital SNHL in recent 
years, with an incidence of up to 10% [3, 64]. However, this is only valid 
for countries with established immunisation programmes against rubella. 
There are some difficulties associated with the diagnosis of CMV infec-
tion, which explains at least partially the hitherto unknown exact inci-
dence and its variation. Diagnosis can only be ascertained in the first 
three weeks of life by detection of the virus in biological fluids such as 
urine or saliva. As confirmation of possible failure of newborn hearing 
screening occurs later, one has to analyse dried blood spots (DBSs). 
Whereas specificity for DBS testing is high, a wide range of sensitivity 
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has been reported. However, a recent study showed high sensitivity can 
be achieved by use of an appropriate extraction method [119]. 
The role of genetics in congenital SNHL has seen the most dramatic 
evolution during the last 15 years and contributes to the aetiological 
identification in various ways. Genetic abnormalities are the leading 
causative factors for SNHL, as seen in table 1 and 3 and confirmed 
through numerous studies [1, 3]. Although the frequency of genetic 
abnormalities was similar to other investigations, the range around the 
median was high. Possible explanations are quite obvious. A restricted 
number of genes were analysed, mainly GJB2, SLC26A4 and mitochon-
drial genes. The first two genes show a highly ethnicity-specific muta-
tion spectrum [120]. In Western Europe, the United States and some 
Asian countries, analysis of Cx26 and SLC26A4 is the most predictive 
diagnostic test [114, 121–124]. Consanguinity is an important issue in 
some countries, for instance 54% in Saudi Arabia, and renders genetic 
analysis and counselling much less precise and more difficult [61]. Just 
about two thirds of the genes involved in the inner ear (out of an estimat-
ed number of about 150) have been identified. For many of the 400 
syndromic forms of hearing loss, genes have yet to be discovered 
(http://hereditaryhearingloss.org). This incomplete knowledge and the 
existing heterogeneity have prevented rapid and cheap analysis up to 
now. New genetic methods, like the microarray technique, show promis-
ing results in reducing costs and increasing the number of genes that can 
be simultaneously screened [125]. Genetic testing can help clarify or 
confirm a syndromic aetiology. Diagnosis of Jervell-Lange-Nielsen 
syndrome is facilitated by a diagnostic score, the so-called Schwartz 
criteria, but definite confirmation is only obtained by genetic analysis. 
Thus, unnecessary medication can be avoided and sudden death in other 
family members prevented [126]. As a prolonged QT interval seems to 
be more prevalent in people with congenital SNHL, an ECG and subse-
quent molecular analysis should be recommended [81, 88–90, 92]. 
Additionally, syndromic identification may allow associated complica-
tions to be anticipated and direct appropriate management. Counselling 
can also be improved in nonsyndromic hearing loss. The confirmation of 
a mutation in GJB2 improves prediction of the outcome of hearing 
rehabilitation [5]. 
Although guidelines have been formulated by various professional 
bodies, they differ in their recommendations [6–8]. The most recent, by 
the British Association of Audiovestibular Physicians, presented a 
detailed search methodology and grading system and largely overlaps 
with the findings of this review. The limitation of this guideline is the 
period covered (just 6 years). 
Limitations of the review 
This study has some limitations. First, a systematic literature review is 
limited by the effectiveness of its predefined search strategy (search 
terms, databases used, inclusion/exclusion criteria, etc.) to identify all the 
relevant articles on the topic of interest. However, the review of refer-
ence lists substantially counteracted this limitation. Nonetheless, relevant 
studies not listed in PubMed or reference lists of included papers might 
have been overlooked. Second, the data are difficult to compare across 
studies as a result of the diversity in study methodology, including 
classification of patients and type of examinations. The total number of 
studies and the high heterogeneity prevented the creation of subgroups 
for possible pooled analysis. Although criteria were established to assess 
the studies, they are subjective and not validated. Third, any conclusion 
of this study is limited by the retrospective analysis. 
Analysis of the current Swiss approach and costs 
The results of the questionnaire sent to the tertiary centres of Switzerland 
reflected the results of the literature review. Examinations were request-
ed and performed with incomplete penetrance. This is especially true for 
genetic analysis, which is expensive. An audit in the UK found that 
guidelines for an aetiological investigation were only partially followed 
[60]. As in Switzerland, lack of funding and parental choice were key 
reasons why the guidelines were not followed. After the successful 
implementation of newborn hearing screening and early identification of 
congenital SNHL, the establishment of a screening programme with 
aetiological focus constitutes an urgent next step in improving the man-
agement of congenital SNHL. 
The costs for full testing amounted to CHF 1720 (Table 5). Preciado et 
al. calculated a cost of 1932 US dollars for a full laboratory workup, 
temporal bone scan and GJB2 screen [53]. The authors proposed a step-
wise approach in order to reduce costs. In view of diagnostic uncertain-
ties and evidence for frequent comorbidities such as ophthalmic and 
neurological findings, we advocate a complete work-up. 
Future directions and recommendations 
An international consensus to establish guidelines for aetiological inter-
ventions and a defined reporting system would increase our knowledge 
of congenital SNHL and improve future management of these patients. 
Recommendations should include directives for organisational manage-
ment to reduce familial stress associated with exhaustive testing and 
increase participation. Financial and local constraints might hinder 
effective implementation of such programmes in countries with limited 
resources. 
Based on this analytic review, we propose a uniform approach to the 
child with congenital SNHL in Switzerland, preferably based on interna-
tional consensus, and recommend following examinations: imaging, 
genetic testing, neuropaediatric and ophthalmological evaluations, ECG 
and CMV analysis. Recommendation of these investigations aims to 
improve counselling and management of these patients and future 
healthcare delivery. 
Conclusion 
With the introduction of newborn hearing screening, aetiological investi-
gation and evaluation of a child with bilateral congenital SNHL has been 
shifted to the first year of life. The evidence in the literature regarding an 
appropriate evaluation is mostly of low quality and difficult to assess 
owing to high heterogeneity. Nevertheless imaging, genetic testing, 
neuropaediatric and ophthalmological evaluations, ECG and CMV 
analysis have been identified as examinations to be included in the 
assessment. There is a need for prospective studies addressing the vari-
ous issues of such an evaluation. 
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Appendix: The Prisma individual patient data flow diagram 
 
 
